Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Purpose Endometriosis is a debilitating disease with high recurrence rates requiring long-term management. Progestins such as dienogest are used empirically when first symptoms occur and post-surgery to reduce recurrence. This retrospective, practice-based study assessed the efficacy and safety of dienogest in women with endometriosis treated for at least 60 months. Methods 37 women (age 39 ± 8 years) with laparoscopically diagnosed endometriosis received dienogest 2 mg orally once daily. Endometriosis-associated pelvic pain (EAPP) was measured on a 0-100 mm visual analog scale at baseline and every 12 months. Laboratory measures of lipid and liver metabolism, hemostatic and hormonal parameters were investigated in a subgroup of 15 women. Adverse events including bleeding disturbances and depressive symptoms were recorded. Results In 22 women, dienogest was begun after laparoscopy; median EAPP score was 70 mm pre-surgery and 10, 10, 20, 20, and 20 mm, respectively, after 12, 24, 36, 48, and 60 months of dienogest treatment. Another 15 women began dienogest without prior surgery; median EAPP score was 80 mm pretreatment and 20, 20, 30, 30, and 30 mm, respectively, after 12, 24, 36, 48, and 60 months. All laboratory parameters remained within the normal range. Mean serum estradiol was 28 ± 12 pg/ml after 60 months. Seven women experienced spotting episodes and four women presented with phases of depressed mood, which could all be clinically managed. Conclusions Long-term (60-mo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term (60-month) treatment effectively reduced endometriosis-associated pain and avoided pain recurrence post-surgery without sever adverse effects [202, 203], especially on bone mineral density (BMD)[189].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [202]
In the citing paper
“Long-term (60-month) treatment effectively reduced endometriosis-associated pain and avoided pain recurrence post-surgery without sever adverse effects [202, 203], especially on bone mineral density (BMD)[189].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [202]
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
The Practice Committee of the American Society for Reproductive Medicine
Birmingham, A. (2006) · Cited by 1,925
Koninckx, P. R., Meuleman, C., Demeyere, S., Lesaffre, E., & Cornillie, F. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54244-7 · Cited by 849
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
Clinical Management of Endometriosis
Falcone, T., & Flyckt, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002469 · Cited by 569
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Endometriosis: Diagnosis and Management
Leyland, N., Casper, R., Laberge, P., Singh, S. S., Allen, L., Arendas, K., Leyland, N., Allaire, C., Awadalla, A., Best, C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34589-3 · Cited by 427
Treatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Use of dienogest in endometriosis: a narrative literature review and expert commentary
Murji, A., Biberoğlu, K., Leng, J., Mueller, M. D., Römer, T., Vignali, M., & Yarmolinskaya, M. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1744120 · Cited by 116
Self-citationA Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment
Chen, L.-H., Lo, W.-C., Huang, H.-Y., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087503 · Cited by 111
Hormonal drugs for the treatment of endometriosis
Capezzuoli, T., Rossi, M., Torre, F. L., Vannuccini, S., & Petraglia, F. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102311 · Cited by 91
The role of pharmacotherapy in the treatment of endometriosis across the lifespan
Schwartz, K. M., Llarena, N. C., Rehmer, J. M., Richards, E. G., & Falcone, T. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1738386 · Cited by 60
Piacenti, I., Viscardi, M. F., Masciullo, L., Sangiuliano, C., Scaramuzzino, S., Piccioni, M. G., Muzii, L., Panici, P. B., & Porpora, M. G. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1892632 · Cited by 58
Effect of Dienogest therapy on the size of the endometrioma
Vignali, M., Belloni, G. M., Pietropaolo, G., Barbasetti Di Prun, A., Barbera, V., Angioni, S., & Pino, I. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1725965 · Cited by 50
“endometriosis treated for at least 60months [42].”
Mitchell, J.-B., Chetty, S., & Kathrada, F. (2022) · BMC Women s Health · doi:10.1186/s12905-022-02122-0 · Cited by 58
Clinical Diagnosis and Early Medical Management for Endometriosis: Consensus from Asian Expert Group
Kim, M.-R., Chapron, C., Römer, T., Aguilar, A., Chalermchockcharoenkit, A., Chatterjee, S., Đào, L. T. A., Fong, Y. F., Hendarto, H., Hidayat, S. T., et al. (2022) · Healthcare · doi:10.3390/healthcare10122515 · Cited by 49
“Römer [78] n = 37 (39 y) DNG 60 mo n EAPP was reduced and post-surgical pain recurrence was avoided n 7 cases of spotting and 4 cases of depressed mood, which were clinically managed”
BackgroundSelf-citationLong-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability
Torre, F. L., Vannuccini, S., Toscano, F., Gallucci, E., Orlandi, G., Manzi, V., & Petraglia, F. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2336121 · Cited by 44
Simancas‐Racines, D., Jiménez-Flores, E., Montalván, M., Horowitz, R., Araujo, V., & Reytor-González, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020908 · Cited by 40
“…benefits in alleviating pain and reducing lesion size, even in deep infiltrating endometriosis and adenomyosis, though its use can be complicated by initial bleeding irregularities and temporary decreases in bone mineral density, especially in adolescents treated for over one year [230,231].”
Techatraisak, K., Hestiantoro, A., Soon, R., Banal-Silao, M. J., Kim, M.-R., Seong, S. J., Hidayat, S. T., Cai, L., Shin, S., & Lee, B. S. (2022) · Reproductive Sciences · doi:10.1007/s43032-021-00787-w · Cited by 40
“5 mm on visual analog scale during 12 months of therapy [40] while Römer reported a decrease in EAPP of 50 mm after 60 months of treatment [41].”
MethodResultHormonal Treatment of Endometriosis: A Narrative Review
Piriyev, E., Schiermeier, S., & Römer, T. (2025) · Pharmaceuticals · doi:10.3390/ph18040588 · Cited by 34
“There is now extensive data supporting the long-term use of dienogest in endometriosis treatment [34,38].”
InfluentialSelf-citationMaiorana, A., Maranto, M., Restivo, V., Gerfo, D. L., Minneci, G., Mercurio, A., & Incandela, D. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07271-7 · Cited by 39
“Excision of endometrial lesions provides rapid symptom relief, but lesion recurrence rates are high, estimated at 40–50% at 5 years [9, 10].”
BackgroundOzaki, R., Kumakiri, J., Jinushi, M., Ikuma, S., Murakami, K., Kawasaki, Y., & Kitade, M. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05691-3 · Cited by 33
Management of women with endometriosis in the 21st century
Sardo, A. D. S., Becker, C. M., Renner, S. P., Suvitie, P. A., Estadella, J., Vannuccini, S., García-Velasco, J. A., Verguts, J., & Mercorio, A. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001027 · Cited by 34
“Extended use for up to 5 years also demonstrated favorable safety outcomes [27,28].”
Nirgianakis, K., Vaineau, C., Agliati, L., McKinnon, B. D., Gasparri, M. L., & Mueller, M. D. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13969 · Cited by 33
Song, S. Y., Park, M., Lee, G. W., Lee, K. H., Chang, H. K., Kwak, S. M., & Yoo, H. J. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.10.014 · Cited by 24
Improved quality of life (EHP-30) in patients with endometriosis after surgical treatment
Neto, J. N., Melo, V. G., Lima, L. C. S., Costa, M., Silva, L. C., Gomes, L. M. R. D. S., Freire, G. I. D. M., Leal, P. D. C., de Oliveira, C. M. B., & Moura, E. C. R. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20230316 · Cited by 24
Surgical treatment of endometriosis: prognostic factors for better quality of life
Vannuccini, S., dos Reis, F. M., Coutinho, L. M., Lazzeri, L., Centini, G., & Petraglia, F. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1616688 · Cited by 26
Niakan, G., Rokhgireh, S., Ebrahimpour, M., & Mehdizadehkashi, A. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.96 · Cited by 23
A systematic review and Bayesian analysis of the adverse effects of dienogest
Li, R.-R., Xi, Q., Tao, L., Wei, S., Zhao, C., & Wu, Y. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00767-1 · Cited by 22
Update on the management of endometriosis-associated pain in France
Fernandez, H., Agostini, A., Baffet, H., Chabbert‐Buffet, N., Descamps, P., Estrade, J.-P., Giraudet, G., Hocké, C., Salle, B., Trémollières, F., et al. (2023) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2023.102664 · Cited by 19
Lee, H. J., Yoon, S., Lee, J. H., Chung, Y., Park, S. Y., Kim, S. W., Hong, Y. H., Kim, S. E., Kim, Y. J., Chun, S., et al. (2024) · Obstetrics & Gynecology Science · doi:10.5468/ogs.24242 · Cited by 21
“When receiving long-term treatment with dienogest, a biannual bone mineral density (BMD) test may be helpful, as well as a breast examination at the same frequency as that for healthy women (grade D) [20-22].”
Wu, Y., Liu, Y., Jia, H., Luo, C., & Chen, H. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.992490 · Cited by 20
Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
Nagashima, N., Hirata, T., Arakawa, T., Neriishi, K., Sun, H. J., Harada, M., Hirota, Y., Koga, K., Wada‐Hiraike, O., & Osuga, Y. (2022) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.02.044 · Cited by 14
Szamatowicz, M., & Hermanowicz-Szamatowicz, K. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1675045 · Cited by 15
“There are many clinical attempts but the data about the pain treatment with the use of dienogest are the subject of the great interest [42].”
Progesterone receptor ligands for the treatment of endometriosis
Clemenza, S., Capezzuoli, T., Eren, E., GARCIA, J. M. G., Vannuccini, S., & Petraglia, F. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05157-0 · Cited by 13
A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms
Kızılkaya, Y., İbanoğlu, M. C., Altınbaş, Ş. K., & Üstün, Y. E. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2053956 · Cited by 11
“reported in 37 women who had previously undergone laparoscopic endometriosis surgery that administration of dienogest for at least 60months was an effective and safe treatment [17].”
BackgroundKrakhotkin, D. V., Silkina, M. N., Chernylovskyi, V. A., & Gayvoronskaya, S. A. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2081492 · Cited by 9
“(Strowitzki et al. 2010; Chandra et al. 2018; R€omer 2018; Osuga et al. 2020).”
Honda, M., Isono, W., Tsuchiya, A., Saito, A., Tsuchiya, H., 玲子, 松., Fujimoto, A., & Nishii, O. (2019) · Journal of Medical Case Reports · doi:10.1186/s13256-019-2236-z · Cited by 9
Role of hormonal therapies in endometriosis: balancing efficacy and safety
Ferrero, S., Paudice, M., Perrone, U., Rosato, F. P., Gullo, G., Vellone, V. G., & Barra, F. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2685064 · Cited by 8
Dienogest-induced major depressive disorder with suicidal ideation: A case report
Lee, S. M., & Park, J. K. (2021) · Medicine · doi:10.1097/md.0000000000027456 · Cited by 11
“In a retrospective practice-based study that assessed the efficacy and safety of dienogest in 37 women with EM treated for at least 60 months, 4 reported occasional phases of depressed mood.([5]) However, psychiatric consultation was not required as the symptoms of depression improved following estrogen treatment.”
BackgroundResultLong-term dienogest treatment in endometriosis: Consensus from Taiwanese experts
Liu, J., Sheu, B., Chang, C. Y.-Y., Yen, C., Wu, M., Chen, Y.-J., Lai, T., Lan, K., Cheng, Y.-M., Tsai, Y.-C., et al. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.07.015 · Cited by 6
Deep infiltrative endometriosis. Contentious issues: pros and cons
Rusina, E. I., Yarmolinskaya, M. I., & Олеговна, П. В. (2020) · GYNECOLOGY · doi:10.26442/20795696.2020.5.200274 · Cited by 5
“Они эффективны для устранения эндометриозассоциированного болевого синдрома [41].”
Outcomes of Laparoscopic Partial Cystectomy of Bladder Endometriosis: A Report of 18 Thai Women
Lertvikool, S., Tingthanatikul, Y., Hongsakorn, W., Srisombut, C., Nakpalat, K., & Weerakiet, S. (2021) · Women s Health Reports · doi:10.1089/whr.2021.0003 · Cited by 6
Approaching ovarian endometrioma with medical therapy
Vignali, M., Solima, E., BARBERA, V., BECHERINI, C., & BELLONI, G. M. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.20.04751-6 · Cited by 5
Hormone therapy for patients with endometriosis: status update on the problem (literature review)
Kozachenko, A. V. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-13-116-123 · Cited by 5
Study of dienogest clinical efficacy in the treatment of adenomyosis
Dobrokhotova, J. E., Магомедовна, К. Д., Ilyina, I. Y., & Grishin, I. I. (2021) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/2284026521993699 · Cited by 4
Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study
Moehner, S., Becker, K., Lange, J. A., von Stockum, S., Serrani, M., & Heinemann, K. (2021) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/2284026521993688 · Cited by 7
Yamamoto, N., Wada‐Hiraike, O., Hirano, M., Hirata, T., Harada, M., Hirota, Y., Koga, K., Fujii, T., & Osuga, Y. (2021) · SAGE Open Medicine · doi:10.1177/20503121211005992 · Cited by 4
Lima, T. T., Mergulhão, B. D. C. R., de Macêdo, R. Z., Peixoto, E. M. R., Emídio, M. S. L., Teixeira, G. L. M., & Barbosa, A. S. L. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n6-246 · Cited by 4
Park, Y., Bae, N., Choo, S. P., Lee, I., Lee, J. H., Kim, Y. J., Cho, S., Choi, Y. S., & Shin, J. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114540 · Cited by 3
The role of pharmacotherapy in the treatment of endometriosis: an update
Imbroane, M. R., Bussies, P. L., Schachter, C., Frankel, L. R., Bosch, A., Santarosa, J., Falcone, T., & Richards, E. G. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2597272 · Cited by 3
Pinto, P. V., Barretta, M., & Grandi, G. (2025) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2025.2589998 · Cited by 3
“Regarding bone health, treatment with DnG 2 mg has been associated with moderate suppression of oestradiol but with levels remaining within the acknowledged therapeutic window for bone health [33].”
Yarmolinskaya, M. I., Denisova, A. S., & Andreeva, N. Y. (2019) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20191903137 · Cited by 4
Zippl, A. L., Mohsin, W. S. Y., Gasser, E., Henninger, B., Widschwendter, A., Kafka‐Ritsch, R., & Seeber, B. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.05.001 · Cited by 4
“Alternative options include the use of dienogest, the progestin hormone with antiproliferative and anti-inflammatory effects (16), or other progestins.”
BackgroundHonda, H., Nishimichi, N., Kaneko, M., Yamashita, M., Akimoto, Y., Tanimoto, H., Teramoto, M., 寺本, 秀., & Yokosaki, Y. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01181-4 · Cited by 3
“However, unlike GnRH analogs, dienogest can be used for long periods and has brought endometriosis patients long-term relief from pain [3].”
BackgroundThe role of progestogens in the treatment of endometriosis
Zhylka, N. Y., & Shcherbinska, O. S. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.8.2023.297794 · Cited by 3
Efficacy of postsurgical medical therapy for infertile patients with deep endometriosis
Skhirtladze, D., Kristesashvili, J., & Charekishvili, R. (2024) · Ginekologia Polska · doi:10.5603/gpl.99414 · Cited by 2
“Administration of progestogens in the postoperative period significantly lowers both menstrual and non-menstrual pelvic pain, improving the quality of life in patients affected by endometriosis [24, 25].”
BackgroundYarmoliskaya, M. I., Petrosyan, М. А., Florova, M. S., Молотков, А. С., Denisova, A. S., Суслова, Е. В., & Tkhazaplizheva, S. S. (2018) · GYNECOLOGY · doi:10.26442/2079-5696_2018.5.46-51 · Cited by 3
Sima, R., Albu, D. N., Ionescu, A. C., Dimitriu, M. C. T., Popescu, M., Tomescu, D. R., Chicea, R., Ceauşu, I., Iordache, I.-I., Poenaru, M. O., et al. (2019) · Revista de Chimie · doi:10.37358/rc.19.4.7158 · Cited by 1
Clinical Guidance Paper VVOG: Pharmacological treatment of endometriosis-related pain
Remans, E., Bafort, C., Blank, C., Bongima, A., Geysenbergh, B., Hamerlynck, T. W. O., Page, G., Verguts, J., & Tomassetti, C. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2025.100403 · Cited by 1
“Prolonged use up to 5 years was also found to be safe [26,27].”
Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review
Yarmolinskaya, M. I., Andreeva, E. N., Bezhenar, V. F., Popov, А. А., & Cherkashina, S. A. (2025) · Journal of obstetrics and women s diseases · doi:10.17816/jowd689557 · Cited by 1
Mohammadian, S., Alan, M. S., Khonsarian, Z. S., Hosseini, K., & Rashidi, H. (2026) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.24200/jogcr.11.9.830 · Cited by 1
Thoracic endometriosis, a review
Guan, X., Rezai, S., Graves, A. G., & Henderson, C. E. (2019) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2019.10.00464 · Cited by 2
Postoperative management of patients with endometriosis
Dobrokhotova, Y. E., Магомедовна, К. Д., & Ilyina, I. Y. (2020) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2020.099 · Cited by 1
Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability
Hryhorenko, A. M. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.61.72-75 · Cited by 1
Uehara, M., Wada‐Hiraike, O., Koga, K., Yamamoto, N., Hirano, M., Harada, M., Hirota, Y., & Osuga, Y. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0158 · Cited by 1
How to Protect Fertility Potential in Endometriosis
Begum, M. R., Ehsan, M., Ehsan, N., & Rashid, F. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2380 · Cited by 1
Efficacy and safety of dienogest versus GnRH-a combined with dienogest therapy for adenomyosisPreprint
Zhu, S., Wang, Q., Sun, J., Xu, W., Zhang, H., Wang, X., Yu, W., & Wang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3509174/v1 · Cited by 1
Покровенко, Д. А., & Medvediev, M. V. (2019) · Scientific digest of association of obstetricians and gynecologists of Ukraine · doi:10.35278/2664-0767.2(44).2019.181216
DIENOGEST IN POST OPERATIVE MANAGEMENT’S OF PATIENT’S WITH ENDOMETRIOSIS
Porsukova, B. D., & Dzhumagulova, D. D. (2020) · Global problems of modernity · doi:10.26787/nydha-2713-2048-2020-1-10-11-12-22-26
Endometriosis, hormonal therapy and oncological risks
Grigorenko, A. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.59.61-65
Honda, H., Nishimichi, N., Yamashita, M., Akimoto, Y., Tanimoto, H., Teramoto, M., 寺本, 秀., & Yokosaki, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-84809/v1
“However, unlike GnRH analogues, dienogest can be used 13 for long periods, and it has brought endometriosis patients long-term relief from the 14 pain [2].”
BackgroundCasais, M., Zabala, A. S., & Rolla, E. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00119-5
Dienogest: Spotting: case report
(2019) · Reactions Weekly · doi:10.1007/s40278-019-68894-6
Medikamentöse Therapie der Endometriose – ein Update
Römer, T. (2022) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-022-00268-6
Self-citationMedikamentöse Therapie der Endometriose – ein Update
Römer, T. (2023) · Wiener klinisches Magazin · doi:10.1007/s00740-023-00494-z
Self-citationMali, M. A. B. B., Fitriana, S. N., Sutrisno, S., Khotimah, H., Wıyasa, I. W. A., Indrawan, I. W. A., & Maharani, M. (2023) · Asian Journal of Health Research · doi:10.55561/ajhr.v2i2.111
“Dienogest is well tolerated, and its side effects are clinically managed [25].”
BackgroundPOSTOPERATIVE PROGESTIN THERAPY FOR PAIN RELIEF IN PATIENTS WITH DEEP ENDOMETRIOSIS
Skhirtladze, D., Kristesashvili, J., & Charekishvili, R. (2023) · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · doi:10.52340/jecm.2023.05.28
Nuevas perspectivas en el abordaje farmacológico del dolor en mujeres con endometriosis.
Guerrero, N. J. A., & García, E. J. V. (2023) · Mediciencias UTA (Impresa)/Mediciencias UTA (En línea) · doi:10.31243/mdc.uta.v7i4.2222.2023
Kumari, P., Ray, R. N., Sarkar, S., Dastidar, S. G., & Munde, Y. (2025) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_113_25
Strong, S. M., Lavington, A., Medina, D., McLaughlin, H., Madhvani, K., & Ball, E. (2025) · doi:10.22541/au.175156697.70025737/v1
Sukhanova, A. A., Gordiіchuk, O., & Tserkovniuk, R. (2025) · Reproductive health of woman · doi:10.30841/2708-8731.4.2025.335429
Additional file 4 of A systematic review and Bayesian analysis of the adverse effects of dienogest
Li, R.-R., Xi, Q., Tao, L., Sheng, W., Zhao, C.-C., & Wu, Y.-J. (2024) · Figshare · doi:10.6084/m9.figshare.26756782
Additional file 2 of A systematic review and Bayesian analysis of the adverse effects of dienogest
Li, R.-R., Xi, Q., Tao, L., Sheng, W., Zhao, C.-C., & Wu, Y.-J. (2024) · Figshare · doi:10.6084/m9.figshare.26756776
Additional file 3 of A systematic review and Bayesian analysis of the adverse effects of dienogest
Li, R.-R., Xi, Q., Tao, L., Sheng, W., Zhao, C.-C., & Wu, Y.-J. (2024) · Figshare · doi:10.6084/m9.figshare.26756779
Mitchell, J.-B., Chetty, S., & Kathrada, F. (2023) · Figshare · doi:10.6084/m9.figshare.22612892
Additional file 1 of A systematic review and Bayesian analysis of the adverse effects of dienogest
Li, R.-R., Xi, Q., Tao, L., Sheng, W., Zhao, C.-C., & Wu, Y.-J. (2024) · Figshare · doi:10.6084/m9.figshare.26756773
Эффективность и безопасность диеногеста в терапии эндометриоза у женщин репродуктивного возраста
Гутикова, Л. В. (2025) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2025.15.6.003
Firoozabadi, Z. D., Derakhshan, R., Chaichian, S., Sabet, B., Hashemi, N. S., & Rokhgireh, S. (2026) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265251366379
Park, J. H., Shin, J., & Kim, M.-R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041664
“…postoperative hormonal therapy in women not seeking immediate conception and evidence that Dienogest 2 mg can be used effectively and safely for up to 60 months [15], we planned to continue medication until the expected age of natural menopause unless contraindications or intolerance occur [16].”
Nigro, A. (2026) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2025-0029 · Cited by 1
Marzec, U., Giza, A., Rajca, E., Cyrkler, A., Cieślak, N., Paulina, G. I. Z. A., Chodkowska, A., Czyżak, K., Dąbek, K., & Wymoczył, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5080
“Progesterone resistance is a common phenomenon in this condition, which leads to poor response to standard progestin therapy in some patients (Schindler, 2011; Römer, 2018).”
Combined Surgical and Hormonal Approach as a Treatment Option for Deep Endometriosis
Skhirtladze, D., Kristesashvili, J., & Charekishvili, R. (2024) · Translational and Clinical Medicine - Georgian Medical Journal
Metadata
- Authors
- Römer, T.
- Affiliations
- University of Cologne (DE)
- Corresponding author
- Römer, Thomas
- ORCID
- Römer, Thomas
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2018-08-03
- Volume
- 298
- Issue
- 4
- Pages
- 747-753
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2885137024
- Cited by
- 82
- References
- 47
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 10 · 2019: 8 · 2018: 2
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-11-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, dienogest, treatment efficacy, drug safety, depressive symptoms, serum estradiol, liver function
- MeSH terms
- Adult, Endometriosis, Female, Humans, Middle Aged, Nandrolone, Retrospective Studies, Pelvic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.